Estabilidad y relación de marcadores neurohormonales según el estadio de insuficiencia cardiaca con disfunción sistólica

García-García, 2010, Trends in in-hospital mortality and six-month outcomes in patients with a first acute myocardial infarction. Change over the last decade, Rev Esp Cardiol, 63, 1136, 10.1016/S0300-8932(10)70245-1 Richards, 2010, Nuevos biomarcadores en la insuficiencia cardiaca: aplicaciones en el diagnóstico, pronóstico y pautas de tratamiento, Rev Esp Cardiol, 63, 635, 10.1016/S0300-8932(10)70155-X Sherwi, 2013, Old an newer biomarkers in heart failure: From pathophysiology to clinical significance, J Cardiovasc Med (Hagerstown), 14, 690, 10.2459/JCM.0b013e328361d1ef Jiménez-Navarro, 2008, Usefulness of natriuretic peptides in heart failure, Med Clin (Barc), 130, 591, 10.1157/13119982 Igbal, 2013, Novel biomarkers for heart failure, Expert Rev Cardiovasc Ther, 11, 1155, 10.1586/14779072.2013.832476 Shah, 2012, Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea, Eur Heart J., 33, 2197, 10.1093/eurheartj/ehs136 Peacock, 2014, Novel biomarkers in acute heart failure: MR-pro-adrenomedullin, Clin Chem Lab Med., 52, 1433, 10.1515/cclm-2014-0222 Freixa, 2011, Usefulness of endothelin-1 assessment in acute myocardial infarction, Rev Esp Cardiol, 64, 105, 10.1016/j.recesp.2010.07.001 Yalta, 2013, Copeptin and cardiovascular disease: A review of a novel neurohormone, Int J Cardiol., 167, 1750, 10.1016/j.ijcard.2012.12.039 Jiménez-Navarro, 2006, Stability of NT-ProBNP in patients with systolic heart failure, Rev Esp Cardiol, 59, 1075, 10.1157/13093987 Wu, 2006, Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results, Am Heart J, 152, 828, 10.1016/j.ahj.2006.08.021 McDowell, 2002, Variability of Nt-proANP and C-ANP, Eur J Clin Invest, 32, 545, 10.1046/j.1365-2362.2002.01031.x Ludka, 2010, Is there circadian variation of big endothelin and NT-proBNP in patients with severe congestive heart failure?, Vnitr Lek, 56, 488 Lassus, 2013, Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study, Int J Cardiol, 168, 2186, 10.1016/j.ijcard.2013.01.228